These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17490)

  • 41. Late-onset acid maltase deficiency. Detection of patients and heterozygotes by urinary enzyme assay.
    Mehler M; DiMauro S
    Arch Neurol; 1976 Oct; 33(10):692-5. PubMed ID: 9923
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preparation of monoclonal antibodies against acid alpha-D-glucosidase for study of Chinese glycogenosis type II patients.
    Lin CY; Lee SY; Chang ZN; Su SN; Hwang B; Han SH
    Hybridoma; 1992 Aug; 11(4):493-505. PubMed ID: 1398685
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Severe course of glycogen storage disease type II (Pompe's disease) without development of cardiomegalia.
    Ullrich K; Gröbe H; Korinthenberg R; von Bassewitz DB
    Pathol Res Pract; 1986 Oct; 181(5):627-32. PubMed ID: 2947052
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prenatal detection of Pompe's disease by induction of alkaline phosphatase in cultured amniotic fluid cells.
    Hähnel R; Stratton CJ; Wysocki SJ; Hockey A
    Aust N Z J Obstet Gynaecol; 1981 Feb; 21(1):43-6. PubMed ID: 7020685
    [No Abstract]   [Full Text] [Related]  

  • 45. Enzyme patterns in glycogen storage disease type II (Pompe's disease).
    Mekanik G; Smith RL; MacLeod RM
    Metabolism; 1966 Jul; 15(7):641-8. PubMed ID: 4288232
    [No Abstract]   [Full Text] [Related]  

  • 46. alpha-Glucosidase deficiency (Pompe's disease).
    Tager JM; Oude Elferink RP; Reuser A; Kroos M; Ginsel LA; Fransen JA; Klumperman J
    Enzyme; 1987; 38(1-4):280-5. PubMed ID: 3126044
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Zonal differences of alpha-glucosidases in human kidney: studies in controls and in patients with glycogenosis type II.
    Pfister K; Gitzelmann R; Steinmann B
    Clin Chim Acta; 1983 Nov; 134(3):307-15. PubMed ID: 6357553
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Subcellular distribution of acid alpha-glucosidase in fibroblasts and of antigenically cross-reactive material in Pompe's disease fibroblasts.
    Iwamasa T; Nashiro K; Ohshita T; Matsuda I
    Histochem J; 1986; 18(11-12):613-24. PubMed ID: 3549635
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of bovine alpha-glucosidase by Castanospermum australe and its effect on the biochemical identification of heterozygotes for generalised glycogenosis type II (Pompe's disease) in cattle.
    Reichmann KG; Twist JO; McKenzie RA; Rowan KJ
    Aust Vet J; 1987 Sep; 64(9):274-6. PubMed ID: 3122715
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The natural course of non-classic Pompe's disease; a review of 225 published cases.
    Winkel LP; Hagemans ML; van Doorn PA; Loonen MC; Hop WJ; Reuser AJ; van der Ploeg AT
    J Neurol; 2005 Aug; 252(8):875-84. PubMed ID: 16133732
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Laboratory diagnosis of the neuromuscular glycogen storage diseases.
    Farmer PM
    Ann Clin Lab Sci; 1982; 12(6):431-8. PubMed ID: 6817693
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lysosomal glycogen storage mimicking the cytological picture of Pompe's disease as induced in rats by injection of an alpha-glucosidase inhibitor. I. Alterations in liver.
    Lüllmann-Rauch R
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1981; 38(1):89-100. PubMed ID: 6119839
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [A retrospective study of six patients with late-onset Pompe disease].
    Saux A; Laforet P; Pagès AM; Figarella-Branger D; Pellissier JF; Pagès M; Labauge P
    Rev Neurol (Paris); 2008 Apr; 164(4):336-42. PubMed ID: 18439925
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The first trimester prenatal diagnosis of Pompe's disease at risk.
    Ezaki M; Sugiyama K; Wada Y; Suzumori K
    Jinrui Idengaku Zasshi; 1987 Sep; 32(3):267-9. PubMed ID: 3329254
    [No Abstract]   [Full Text] [Related]  

  • 55. [Three hypotonic neonates with hypertrophic cardiomyopathy: Pompe's disease].
    Willemsen MA; Jira PE; Gabreëls FJ; van der Ploeg AT; Smeitink JA
    Ned Tijdschr Geneeskd; 1998 Jun; 142(24):1388-92. PubMed ID: 9752027
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Pompe's disease--acid alpha-glucosidase deficiency--a review].
    Iwamasa T; Chinen K; Hirayasu T
    Nihon Rinsho; 1993 Sep; 51(9):2324-9. PubMed ID: 8411709
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Enzyme replacement therapy in Pompe's disease].
    Merk T; Wibmer T; Schumann C; Krüger S
    Med Klin (Munich); 2007 Jul; 102(7):570-3. PubMed ID: 17634875
    [TBL] [Abstract][Full Text] [Related]  

  • 58. alpha-Glucosidase deficiency in generalized glycogenstorage disease (Pompe's disease).
    HERS HG
    Biochem J; 1963 Jan; 86(1):11-6. PubMed ID: 13954110
    [No Abstract]   [Full Text] [Related]  

  • 59. [Pompe's disease. Part I: pathogenesis and clinical features].
    Illés Z; Trauninger A
    Ideggyogy Sz; 2009 Jul; 62(7-8):231-43. PubMed ID: 19685701
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Echocardiographic evidence of outflow tract obstruction in Pompe's disease (glycogen storage disease of the heart).
    Rees A; Elbl F; Minhas K; Solinger R
    Am J Cardiol; 1976 Jun; 37(7):1103-6. PubMed ID: 132116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.